These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 27409165

  • 1. Nuclear IKKα mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression.
    Chen WS, Liu LC, Yen CJ, Chen YJ, Chen JY, Ho CY, Liu SH, Chen CC, Huang WC.
    Oncotarget; 2016 Aug 30; 7(35):56309-56323. PubMed ID: 27409165
    [Abstract] [Full Text] [Related]

  • 2. miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin.
    Chen WS, Yen CJ, Chen YJ, Chen JY, Wang LY, Chiu SJ, Shih WL, Ho CY, Wei TT, Pan HL, Chien PH, Hung MC, Chen CC, Huang WC.
    Oncotarget; 2015 Sep 22; 6(28):25962-74. PubMed ID: 26296971
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus X protein induces IKKα nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells.
    Huang WC, Chen WS, Chen YJ, Wang LY, Hsu SC, Chen CC, Hung MC.
    J Cell Physiol; 2012 Apr 22; 227(4):1446-54. PubMed ID: 21618535
    [Abstract] [Full Text] [Related]

  • 4. Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma.
    Li W, Li M, Liao D, Lu X, Gu X, Zhang Q, Zhang Z, Li H.
    Oncotarget; 2016 Aug 23; 7(34):55110-55127. PubMed ID: 27391153
    [Abstract] [Full Text] [Related]

  • 5. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G, Chen X, Chen S, Ye W, Hou K, Liang M.
    J Transl Med; 2016 May 05; 14(1):122. PubMed ID: 27150195
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
    Zhang T, Zhang J, Cui M, Liu F, You X, Du Y, Gao Y, Zhang S, Lu Z, Ye L, Zhang X.
    Neoplasia; 2013 Nov 05; 15(11):1282-91. PubMed ID: 24339740
    [Abstract] [Full Text] [Related]

  • 7. High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer.
    Jiang R, Xia Y, Li J, Deng L, Zhao L, Shi J, Wang X, Sun B.
    Int J Cancer; 2010 Mar 01; 126(5):1263-74. PubMed ID: 19728335
    [Abstract] [Full Text] [Related]

  • 8. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.
    Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554
    [Abstract] [Full Text] [Related]

  • 9. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H, Fan D, Nie Y, Wu K.
    J Hepatol; 2012 Sep 10; 57(3):600-12. PubMed ID: 22613004
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
    Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC, Wu CY, Yu YL.
    Int J Cancer; 2014 Apr 01; 134(7):1638-47. PubMed ID: 24122375
    [Abstract] [Full Text] [Related]

  • 11. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
    Ng KY, Chai S, Tong M, Guan XY, Lin CH, Ching YP, Xie D, Cheng AS, Ma S.
    Oncotarget; 2016 Apr 26; 7(17):24005-17. PubMed ID: 27006468
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, Chen Y.
    Eur J Cancer; 2014 Oct 26; 50(15):2560-9. PubMed ID: 25087183
    [Abstract] [Full Text] [Related]

  • 14. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
    Kim HY, Jung HU, Yoo SH, Yoo KS, Cheong J, Park BS, Yun I, Yoo YH.
    Cancer Lett; 2014 Dec 01; 355(1):61-9. PubMed ID: 25218348
    [Abstract] [Full Text] [Related]

  • 15. HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma.
    Liu X, Zhang Y, Wang P, Wang H, Su H, Zhou X, Zhang L.
    Med Sci Monit; 2016 Jul 16; 22():2492-500. PubMed ID: 27421245
    [Abstract] [Full Text] [Related]

  • 16. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.
    Chen JY, Chen YJ, Yen CJ, Chen WS, Huang WC.
    Oncotarget; 2016 Jan 05; 7(1):473-89. PubMed ID: 26595522
    [Abstract] [Full Text] [Related]

  • 17. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ.
    World J Gastroenterol; 2016 Jun 14; 22(22):5183-92. PubMed ID: 27298561
    [Abstract] [Full Text] [Related]

  • 18. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
    Qu S, Jin L, Huang H, Lin J, Gao W, Zeng Z.
    BMC Cancer; 2021 Jun 10; 21(1):686. PubMed ID: 34112124
    [Abstract] [Full Text] [Related]

  • 19. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP, Wu WK, Kang W, Lee YY, Wu F, Yu Z, Xiong L, Chan AW, Tong JH, Yang W, Li MS, Lau SS, Li X, Lee SD, Yang Y, Lai PB, Yu DY, Xu G, Lo KW, Chan MT, Wang H, Lee TL, Yu J, Wong N, Yip KY, To KF, Cheng AS.
    J Pathol; 2016 Apr 10; 238(5):651-64. PubMed ID: 26800240
    [Abstract] [Full Text] [Related]

  • 20. IKKα inibition by a glucosamine derivative enhances Maspin expression in osteosarcoma cell line.
    Leopizzi M, Cocchiola R, Milanetti E, Raimondo D, Politi L, Giordano C, Scandurra R, Scotto d'Abusco A.
    Chem Biol Interact; 2017 Jan 25; 262():19-28. PubMed ID: 27931795
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.